Showing 1-5 of 42 outcomes & condition management:
OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic Rhinosinusitis

Utilizing clinical data from electronic health records related to endoscopic sinus surgeries, Medtronic and OM1 found PROPEL devices result in fewer postoperative care needs in chronic rhinosinusitis patients   April 09, 2024 09:00 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–OM1, the leading AI and insights-driven technology and data company specializing in personalized medicine, evidence generation, and[…]

Real-World Analysis & Insights from the OM1 Neuroscience Specialty Network

OM1 is reimagining real-world evidence with the development of large, electronically connected networks of clinicians in key specialty areas. This ebook explores powerful insights, analyses, and use cases that leverage AI and data science from OM1’s Neuroscience Specialty Network. View ebook >>

Understanding How Data Analytics Help Improve Health Outcomes With Stefan Weiss, MD

Dermatology Times Jun 6, 2023 Stefan Weiss, MD, MHSc, MBA Kaitlyn Bader, Senior Editor Watch the video >> OM1 is a large-scale data analytics company with a dedication to improving health outcomes through targeted research. Dermatology Times® recently spoke with Stefan Weiss, MD, MHSc, MBA, a board-certified dermatologist and the managing director of dermatology at OM1, to discuss the[…]

Defining Treatment-Resistant Depression

Psychiatric Times May 21, 2023 Carl D. Marci, MD Steven P. Levine, MD Watch the video>> Carl D. Marci, MD, and Steven P. Levine, MD, caught up with Psychiatric Times in this exclusive video after their session, “Treatment Resistant Depression From Multiple Perspectives: Does It Exist?“ Learn more about 3 potential definitions of treatment resistant depression and[…]

1 2 3 … 9